Global Small Molecule Inhibitors Market Analysis By Drug Class (Kinase Inhibitors (Tyrosine Kinase Inhibitors (TKIs) (EGFR inhibitors, ALK inhibitors, BTK inhibitors, VEGFR/FGFR inhibitors), Serine/Threonine Kinase Inhibitors (CDK inhibitors, mTOR/PI3K/AKT inhibitors, MEK/BRAF inhibitors)), Proteasome Inhibitors, MMPs and HSPs inhibitors, Small molecule inhibitors targeting the apoptosis, Immunomodulatory Small Molecule Inhibitors, Others), By Therapeutic Area (Oncology, Immunology & Autoimmune Disorders, Infectious Diseases, Neurology, Rare Diseases & Genetic Disorders, Others), By Route of Administration (Oral, Intravenous), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034